Related Experiment Video
Updated: Jul 4, 2026
10:08
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
Published on: November 22, 2024
Factor VIIa interaction with tissue factor and endothelial cell protein C receptor on cell surfaces
Usha R Pendurthi1, L Vijaya Mohan Rao
1Biomedical Research, The University of Texas Health Center at Tyler, Tyler, TX 75708, USA.
Seminars in Hematology
|July 17, 2008
Summary
Factor VIIa (FVIIa) binds tissue factor (TF) to initiate blood clotting. Interactions with TF and EPCR regulate FVIIa activity and clearance, impacting coagulation.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Factor VIIa (FVIIa) is a key enzyme initiating the coagulation cascade.
- Tissue Factor (TF) is a cellular receptor that significantly enhances FVIIa enzymatic activity.
- Endothelial Cell Protein C Receptor (EPCR) also binds FVIIa, but without enhancing its activity.
Purpose of the Study:
- To review current knowledge on FVIIa interactions with TF and EPCR.
- To explore how these cell surface interactions influence FVIIa and TF clearance.
- To understand the regulation of TF-FVIIa activity through these binding events.
Main Methods:
- Literature review of FVIIa-TF and FVIIa-EPCR interactions.
- Analysis of studies on cellular receptor-mediated clearance mechanisms.
- Synthesis of data on the functional consequences of these complexes.
Main Results:
- FVIIa-TF association is critical for initiating blood coagulation.
- FVIIa-EPCR complex formation does not enhance FVIIa enzymatic activity.
- Both TF and EPCR interactions are implicated in the clearance of FVIIa and TF.
Conclusions:
- Cell surface interactions with TF and EPCR play a crucial role in regulating FVIIa activity.
- These interactions are essential for controlling the clearance of FVIIa and TF, thereby modulating coagulation.
- Understanding these mechanisms provides insights into the regulation of the coagulation pathway.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...